TickerFiles

AIM ImmunoTech Inc. 10-K filing

Filed 2026-03-27 · Report date 2025-12-31 · 2025 FY

View Original SEC Filing

Filing metadata

Accession number
0001493152-26-013301
Form type
10-K
CIK
0000946644
Primary document
https://www.sec.gov/Archives/edgar/data/946644/000149315226013301/form10-k.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for AIM ImmunoTech Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$88,000--
Operating Income$-11.7M--
Net Income$-14.0M--
Eps Basic-8.62--
Eps Diluted-8.62--
Cash And Equivalents$3.0M--
Total Assets$5.8M--
Total Liabilities$15.6M--
Shareholders Equity$-9.8M--
Operating Cash Flow$-11.0M--
Capital Expenditures$18,000--